Skip to main content
MedPathMedPath Home
Clinical Trials/NCT03639649
NCT03639649
Completed
Not Applicable

STHLM3 - Prostate Cancer Diagnostic Trial

Karolinska Institutet1 site in 1 country58,818 target enrollmentAugust 2013
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
ConditionsProstate Cancer

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Prostate Cancer
Sponsor
Karolinska Institutet
Enrollment
58818
Locations
1
Primary Endpoint
Number of biopsies
Status
Completed
Last Updated
7 years ago
OverviewInvestigatorsEligibility CriteriaOutcomesSitesSimilar Trials

Overview

Brief Summary

STHLM3 is a paired diagnostic trial aiming to assess whether a panel of biomarkers for prostate cancer can substantially reduce the proportion of men referred to biopsy whilst maintaining sensitivity for aggressive prostate cancer

Registry
clinicaltrials.gov
Start Date
August 2013
End Date
February 2015
Last Updated
7 years ago
Study Type
Interventional
Study Design
Single Group
Sex
Male

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Henrik Grönberg

Professor

Karolinska Institutet

Eligibility Criteria

Inclusion Criteria

  • •Age 50-69
  • •Residential address in Stockholm County

Exclusion Criteria

  • •Previous Prostate Cancer Diagnosis
  • •Not able to comprehend inform consent material

Outcomes

Primary Outcomes

Number of biopsies

Time Frame: Recorded directly after biopsy

Secondary Outcomes

  • Number of Gleason Score ≥ 7(Recorded directly after biopsy)
  • Number of Gleason Score 6(Recorded directly after biopsy)
  • Number of benign(Recorded directly after biopsy)

Study Sites (1)

Loading locations...

Similar Trials

Completed
Not Applicable
STHLM3 - Prostate cancer diagnostic trialProstate cancerCancerMalignant neoplasm of prostate
ISRCTN84445406Karolinska Institutet (Sweden)140,000
Active, not recruiting
Not Applicable
Prostate Cancer Detection Using the Stockholm3 Test and MR/Fusion BiopsiesProstate Cancer
NCT03377881Karolinska Institutet12,750
Completed
Not Applicable
STHLM3-MR: Comparing Standard With Targeted Prostate BiopsiesProstate Cancer
NCT02788825Karolinska Institutet687
Completed
Phase 3
Study of Immunotherapy to Treat Advanced Prostate CancerProstate Cancer
NCT00861614Bristol-Myers Squibb988
Completed
Not Applicable
Active Surveillance for Low-risk Prostate Cancer - Evaluation of the Efficacy of Minimally Invasive Active SurveillanceProstate Cancer
NCT03956108Karolinska Institutet280